Emodin Inhibits Inflammation, Carcinogenesis, and Cancer Progression in the AOM/DSS Model of Colitis-Associated Intestinal Tumorigenesis
Colorectal cancer (CRC) is one of the most common cancer worldwide. Chronic inflammation contributes to CRC development and progression. Emodin, is a natural anthraquinone derivative with anti-oxidant, anti-inflammatory, and anti-tumor activities. We used the AOM/DSS model of colitis-associated inte...
Main Authors: | Yunsha Zhang, Weiling Pu, Mélanie Bousquenaud, Sarah Cattin, Jelena Zaric, Li-kang Sun, Curzio Rüegg |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-01-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2020.564674/full |
Similar Items
-
Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis
by: Zibo Li, et al.
Published: (2019-03-01) -
Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
by: Chung-Chun Wu, et al.
Published: (2019-11-01) -
Bioconcentration and Metabolism of Emodin in Zebrafish Eleutheroembryos
by: Jiefeng Chen, et al.
Published: (2017-07-01) -
Anti-inflammatory mechanism of emodin in rats with Aspergillus fumigatus keratitis
by: Xiao-Mei Gou, et al.
Published: (2019-08-01) -
Anti-SARS-CoV and Anti-cancer Effects of Emodin
by: Mohammad Hossein Ghaffari Agdam, et al.
Published: (2019-08-01)